Brain Imaging and Pain in Irritable Bowel Syndrome - Full Text View

Brain Imaging and Pain in Irritable Bowel Syndrome

This study has been completed.

Sponsors and Collaborators:	National Center for Complementary and Alternative Medicine (NCCAM) National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by:	National Center for Complementary and Alternative Medicine (NCCAM)
ClinicalTrials.gov Identifier:	NCT00065754

Purpose

This study examines the mechanisms, including brain imaging of placebo analgesia

Condition	Intervention
Irritable Bowel Syndrome	Drug: placebo

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Other, Randomized, Double-Blind, Factorial Assignment

Official Title:	Brain Imaging and Pain: Analysis of Placebo Analgesia

Further study details as provided by National Center for Complementary and Alternative Medicine (NCCAM):

Estimated Enrollment:	50
Study Start Date:	September 2003
Study Completion Date:	December 2007
Primary Completion Date:	December 2007 (Final data collection date for primary outcome measure)

Eligibility

Criteria

Inclusion criteria:

Exclusion criteria:

Chronic pain condition other than Irritable Bowel Syndrome
Medical condition that would contraindicate use of lidocaine
Clinical criteria for fibromyalgia
Presence of systemic disease such as diabetes, thyroid, gastrointestinal or liver disease, collagen vascular disease, malignancy, focal or neurological
Seropositive HIV
Pregnancy

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00065754

Locations


United States, Florida
	University of Florida
	Gainesville, Florida, United States, 32610

Sponsors and Collaborators

National Center for Complementary and Alternative Medicine (NCCAM)

Investigators


Principal Investigator:	Michael E Robinson, PhD	University of Florida

More Information

Study ID Numbers:	R01 AT001424-01
First Received:	July 31, 2003
Last Updated:	August 4, 2008
ClinicalTrials.gov Identifier:	NCT00065754
Health Authority:	United States: Federal Government

Keywords provided by National Center for Complementary and Alternative Medicine (NCCAM):

Placebo

Analgesia

Pain

Brain mechanism

Expectation

Study placed in the following topic categories:

Digestive System Diseases

Gastrointestinal Diseases

Colonic Diseases

Irritable Bowel Syndrome

Pain

Intestinal Diseases

Colonic Diseases, Functional

Additional relevant MeSH terms:

Pathologic Processes

Disease

Syndrome

ClinicalTrials.gov processed this record on October 17, 2008